Also, MS men had significantly higher activated CD3+CD56+CD8+ cells than healthy men [8.39 (5.89–27.02) vs. 3.93 (2.04–6.53), p = 0.017] (Figure 4), suggesting its relevance in MS pathophysiology. This evidence concerns the gene CD8A and myeloid sarcoma.